These drugs offer dual benefits, improving glycemic control while boosting weight loss, which makes them a preferred option in managing both type 2 diabetes and obesity
Combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors is not appropriate for all patients with type 2 diabetes, and careful patient selection is essential
The Tinsley and Nadolsky case series (2025) found that patients on GLP-1 medications who did resistance training three to five days per week, even at sessions as short as 15-45 minutes, had dramatically better lean mass outcomes than typical trial participants
Impact on Aesthetics Practices Aesthetics practices offering weight loss programs may face challenges as compounded Semaglutide becomes unavailable
Chronic poor sleep stretches your timeline
Stay hydrated: drink plenty of water.Eat mindfully: slow down, savor food, avoid distractions